Orion Biotech 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
5P12-RANTES / Orion Biotech
NCT05940844: Study of OB-002 in Patients With Refractory Metastatic Cancer

Withdrawn
1
36
NA
OB-002
Orion Biotechnology Polska Sp. z o.o.
Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Urothelial Carcinoma
04/25
08/25
OB-002 topical / Orion Biotech
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
5P12-RANTES / Orion Biotech
NCT05940844: Study of OB-002 in Patients With Refractory Metastatic Cancer

Withdrawn
1
36
NA
OB-002
Orion Biotechnology Polska Sp. z o.o.
Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Urothelial Carcinoma
04/25
08/25
OB-002 topical / Orion Biotech
No trials found

Download Options